| Jensen LO, Maeng M, Thayssen P, et al.
Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. [JOURNAL ARTICLE]
Eur Heart J 2008 Oct 2.
Abstract | Full Citation | | Casado P, Prado MA, Zuazua-Villar P, et al.
Microtubule interfering agents and KSP inhibitors induce the phosphorylation of the nuclear protein p54(nrb), an event linked to G2/M arrest. [JOURNAL ARTICLE]
J Proteomics 2008 Sep 14.
Abstract | Full Citation | | Takeda A, Loveman E, Harris P, et al.
Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review. [Journal Article]
Health Technol Assess 2008 Oct; 12(32):1-68.
Abstract | Full Citation | | Kutuk O, Letai A
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737. [Journal Article, Research Support, N.I.H., Extramural]
Cancer Res 2008 Oct 1; 68(19):7985-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dai CL, Tiwari AK, Wu CP, et al.
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. [Journal Article, Research Support, Non-U.S. Gov't]
Cancer Res 2008 Oct 1; 68(19):7905-14.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hirsch FR, Varella-Garcia M, Dziadziuszko R, et al.
Fluorescence In situ Hybridization Subgroup Analysis of TRIBUTE, a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer. [Journal Article]
Clin Cancer Res 2008 Oct 1; 14(19):6317-23.
Abstract | Full Citation | Find Related Articles | | Karmali PP, Kotamraju VR, Kastantin M, et al.
Targeting of albumin-embedded paclitaxel nanoparticles to tumors. [JOURNAL ARTICLE]
Nanomedicine 2008 Sep 30.
Abstract | Full Citation | | Sabbatini P, Sill MW, O'Malley D, et al.
A phase II trial of paclitaxel poliglumex in recurrent or persistent ovarian or primary peritoneal cancer (EOC): A gynecologic oncology group study. [JOURNAL ARTICLE]
Gynecol Oncol 2008 Sep 29.
Abstract | Full Citation | | Duan Z, Choy E, Jimeno JM, et al.
Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Oct 1.
Abstract | Full Citation | | Felip E, Rosell R
Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC). [Journal Article]
Ther Clin Risk Manag 2008 Jun; 4(3):579-85.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
